We are live on ! Find out more
SGAM

Smith Group Asset Management Portfolio holdings

AUM $2.46B
1-Year Est. Return 57.16%
This Fund
S&P 500
This Quarter Est. Return
+2.2%
1 Year Est. Return
+57.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.84B
AUM Growth
-$136M
Cap. Flow
-$158M
Cap. Flow %
-5.56%
Top 10 Hldgs %
32.15%
Holding
473
New
70
Increased
58
Reduced
178
Closed
96

Top Buys

Rank Stock Value
1
BURL icon
Burlington
BURL
+$39.8M
2
LHX icon
L3Harris
LHX
+$36.3M
3
AMGN icon
Amgen
AMGN
+$32M
4
DAL icon
Delta Air Lines
DAL
+$27M
5
CIEN icon
Ciena
CIEN
+$26.2M

Top Sells

Rank Stock Value
1
TRIP icon
TripAdvisor
TRIP
+$48M
2
NSC icon
Norfolk Southern
NSC
+$32.6M
3
ADBE icon
Adobe
ADBE
+$32.3M
4
AAP icon
Advance Auto Parts
AAP
+$32.1M
5
NTAP icon
NetApp
NTAP
+$29.6M

Sector Composition

Rank Sector Weight
1 Technology 33.08%
2 Healthcare 13.95%
3 Consumer Discretionary 12.73%
4 Communication Services 11.1%
5 Industrials 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AROC icon
226
Archrock
AROC
$5.81B
$126K ﹤0.01%
12,640
– –
BRK.B icon
227
Berkshire Hathaway Class B
BRK.B
$1.13T
$125K ﹤0.01%
601
-31
-5% -$6.39K
LAB icon
228
Standard BioTools
LAB
$310M
$116K ﹤0.01%
24,960
– –
HZNP
229
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$115K ﹤0.01%
4,210
– –
RGEN icon
230
Repligen
RGEN
$9.21B
$114K ﹤0.01%
1,490
+340
+30% +$29.7K
TPCO
231
DELISTED
Tribune Publishing Company Common Stock
TPCO
$114K ﹤0.01%
13,278
– –
FLWS icon
232
1-800-Flowers.com
FLWS
$255M
$113K ﹤0.01%
7,640
-6,000
-44% -$104K
GTS
233
DELISTED
Triple-S Management Corporation
GTS
$113K ﹤0.01%
8,424
-1
-0% -$21
RCM
234
DELISTED
R1 RCM Inc. Common Stock
RCM
$112K ﹤0.01%
+12,550
New +$148K
ONCE
235
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$112K ﹤0.01%
+1,160
New +$116K
APYX icon
236
Apyx Medical
APYX
$146M
$110K ﹤0.01%
16,200
– –
OSUR icon
237
OraSure Technologies
OSUR
$276M
$105K ﹤0.01%
14,001
– –
AMPY icon
238
Amplify Energy
AMPY
$172M
$99K ﹤0.01%
16,100
– –
GBT
239
DELISTED
Global Blood Therapeutics, Inc.
GBT
$97K ﹤0.01%
2,000
+320
+19% +$16.7K
ZUMZ icon
240
Zumiez
ZUMZ
$330M
$96K ﹤0.01%
3,020
– –
ARWR icon
241
Arrowhead Research
ARWR
$12.5B
$95K ﹤0.01%
+3,360
New +$99.4K
AVH
242
DELISTED
AVIANCA HOLDINGS S.A.
AVH
$95K ﹤0.01%
26,016
– –
EBS icon
243
Emergent Biosolutions
EBS
$229M
$94K ﹤0.01%
1,790
+320
+22% +$14.9K
HBCP icon
244
Home Bancorp
HBCP
$556M
$91K ﹤0.01%
2,340
– –
KYNB
245
Kyntra Bio
KYNB
$28.2M
$89K ﹤0.01%
97
+13
+15% +$14.3K
RARE icon
246
Ultragenyx Pharmaceutical
RARE
$2.64B
$86K ﹤0.01%
2,000
+320
+19% +$17.4K
HALO icon
247
Halozyme
HALO
$11.6B
$83K ﹤0.01%
5,350
+1,370
+34% +$22.6K
BSRR icon
248
Sierra Bancorp
BSRR
$516M
$82K ﹤0.01%
3,105
– –
ARCT icon
249
Arcturus Therapeutics
ARCT
$200M
$81K ﹤0.01%
+7,890
New +$85.3K
EGRX
250
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$78K ﹤0.01%
1,372
– –
8 9
10
11 12

Similar funds

M
Mirova Paris, France $2.46B AUM 11.42% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.45B AUM 39.53% 1-Year Est. Return
QT
Quantbot Technologies New York $2.44B AUM 17.13% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
TW
Trajan Wealth Scottsdale, Arizona $2.48B AUM 17.44% 1-Year Est. Return
KFA
Krane Funds Advisors New York $2.44B AUM 12.99% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $2.48B AUM 72.25% 1-Year Est. Return
FFA
First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return

Smith Group Asset Management's Q3 2019 Portfolio in Review

As of Q3 2019, Smith Group Asset Management held 473 positions worth $2.84B, down 4.5% from $2.98B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Smith Group Asset Management withdrew a net $158M in Q3 2019, closing 96 positions and reducing 178 holdings. Its most notable exit was TripAdvisor, an estimated $48M position sold in full.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Smith Group Asset Management opened a new position in Burlington worth $43.2M.

  • Smith Group Asset Management's largest Q3 2019 buy was Burlington: 216,261 shares worth $43.2M.
  • Smith Group Asset Management added most to Emcor in Q3 2019, an estimated $24M increase.
  • Smith Group Asset Management's biggest Q3 2019 reduction was Adobe, cutting an estimated $32.3M.
  • Smith Group Asset Management fully exited TripAdvisor in Q3 2019, selling an estimated $48M.
  • Smith Group Asset Management's ten largest holdings make up 32% of its $2.84B portfolio in Q3 2019.
  • Smith Group Asset Management opened 70 new positions and closed 96 in Q3 2019.
  • Smith Group Asset Management's portfolio value fell 4.5% quarter-over-quarter to $2.84B.

Based on Smith Group Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.